PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003:: implications for the design of an outer membrane protein-based vaccine

被引:12
|
作者
Pereira, Cecilia Sorhouet [1 ,2 ]
Regueira, Mabel [2 ]
Mollerach, Marta [1 ]
机构
[1] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Microbiol, RA-1113 Buenos Aires, DF, Argentina
[2] Inst Nacl Enfermadades Infecciosas, Dept Bacteriol, RA-1281 Buenos Aires, DF, Argentina
关键词
D O I
10.1099/jmm.0.47631-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Identification of Neisseria meningitidis PorA types remains important, as the PorA protein is a major immunogenic component of several meningococcal vaccines under development. In this study, 191 N. meningitidis serogroup B isolates collected in Argentina through active laboratory-based surveillance from 2001 to 2003 were serosubtyped. Nucleotide sequences of the porA variable region 1 (VR1) and VR2 regions were determined in 52 non-serosubtypeable isolates. A substantial number of distinct VIR types were identified, and a new VR2 variant from the P1.16 family was described. This is the first report describing PorA types in N. meningitidis serogroup B isolates in Argentina. Furthermore, the wide diversity of subtypes detected by serosubtyping and genosubtyping reveals the difficulty in designing a useful outer-membrane vaccine applicable in this country. A possible mechanism responsible for altered PorA expression was analysed in two PorA types.
引用
收藏
页码:338 / 342
页数:5
相关论文
共 50 条
  • [31] Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strains
    Matthias, Kathryn A.
    Reveille, Alexandra
    Connolly, Kristie L.
    Jerse, Ann E.
    Gao, Yamei S.
    Bash, Margaret C.
    VACCINE, 2020, 38 (10) : 2396 - 2405
  • [32] PURIFICATION AND CHARACTERIZATION OF 8 CLASS-5 OUTER-MEMBRANE PROTEIN VARIANTS FROM A CLONE OF NEISSERIA-MENINGITIDIS SEROGROUP-A
    ACHTMAN, M
    NEIBERT, M
    CROWE, BA
    STRITTMATTER, W
    KUSECEK, B
    WEYSE, E
    WALSH, MJ
    SLAWIG, B
    MORELLI, G
    MOLL, A
    BLAKE, M
    JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (02): : 507 - 525
  • [33] IMMUNOGENICITY IN INFANTS OF HAEMOPHILUS-INFLUENZAE TYPE-B POLYSACCHARIDE IN A CONJUGATE VACCINE WITH NEISSERIA MENINGITIDIS OUTER-MEMBRANE PROTEIN
    EINHORN, MS
    WEINBERG, GA
    ANDERSON, EL
    GRANOFF, PD
    GRANOFF, DM
    LANCET, 1986, 2 (8502): : 299 - 302
  • [34] Heterogeneity in non-epitope loop sequence and outer membrane protein complexes alters antibody binding to the major porin protein PorB in serogroup B Neisseria meningitidis
    Matthias, Kathryn A.
    Strader, Michael Brad
    Nawar, Hesham F.
    Gao, Yamei S.
    Lee, Joonseong
    Patel, Dhilon S.
    Im, Wonpil
    Bash, Margaret C.
    MOLECULAR MICROBIOLOGY, 2017, 105 (06) : 934 - 953
  • [35] Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland
    Perkins, BA
    Jonsdottir, K
    Briem, H
    Griffiths, E
    Plikaytis, BD
    Hoiby, EA
    Rosenqvist, E
    Holst, J
    Nokleby, H
    Sotolongo, F
    Sierra, G
    Campa, HC
    Carlone, GM
    Williams, D
    Dykes, J
    Kapczynski, D
    Tikhomirov, E
    Wenger, JD
    Broome, CV
    JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03): : 683 - 691
  • [36] Population coverage analysis of T-Cell epitopes of Neisseria meningitidis serogroup B from Iron acquisition proteins for vaccine design
    Misra, Namrata
    Panda, Prasanna Kumar
    Shah, Kavita
    Sukla, Lala Bihari
    Chaubey, Priyanka
    BIOINFORMATION, 2011, 6 (07) : 255 - 261
  • [37] Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Neisseria meningitidis Isolated from 2009 to 2013 in the Republic of Ireland
    Mulhall, Robert M.
    Bennett, Desiree
    Cunney, Robert
    Borrow, Ray
    Lucidarme, Jay
    Findlow, Jamie
    Jolley, Keith A.
    Bray, James
    Maiden, Martin C. J.
    Moschioni, Monica
    Serino, Laura
    Stella, Maria
    Medini, Duccio
    MSPHERE, 2018, 3 (04):
  • [38] Comparison among opsonic activity and serum bactericidal activity against Meningococci in rabbit sera from vaccines after immunisation with the Neisseria meningitidis serogroup A capsular polysaccharide-serogroup B outer membrane vesicle conjugate vaccine
    Siadat, S.
    Barzegar, H. Najafi
    Behzadiyannejad, Q.
    Tabaraiee, B.
    Ahmadi, H.
    Shamasbi, D. Nourouzian
    Peerayeh, S. Najar
    Nejati, M.
    Zangeneh, M.
    Motlagh, B. Adibi
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S292 - S293
  • [39] Comparison and correlation of Neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac
    Findlow, Jamie
    Taylor, Stephen
    Aase, Audun
    Horton, Rachel
    Heyderman, Robert
    Southern, Jo
    Andrews, Nick
    Barchha, Rita
    Harrison, Ewan
    Lowe, Ann
    Boxer, Emma
    Heaton, Charlotte
    Balmer, Paul
    Kaczmarski, Ed
    Oster, Philipp
    Gorringe, Andrew
    Borrow, Ray
    Miller, Elizabeth
    INFECTION AND IMMUNITY, 2006, 74 (08) : 4557 - 4565
  • [40] An experimental outer membrane vesicle vaccine from N. meningitidis serogroup B strains that induces serum bactericidal activity to multiple serogroups
    Pinto, Valerian B.
    Moran, Elizabeth E.
    Cruz, Francisco
    Wang, Xin-Ming
    Fridman, Arthur
    Zollinger, Wendell D.
    Przysiecki, Craig T.
    Burden, Robert
    VACCINE, 2011, 29 (44) : 7752 - 7758